Lead investigator discusses Novavax approval with Orlando TV station - Accel Research Sites

Create a Profile

I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.
Create a Profile
I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location
Back
Date Published: 07/21/2022

Lead investigator discusses Novavax approval with Orlando TV station

The FDA recently approved the Novavax vaccine for COVID-19.

Dr. Bruce Rankin worked on clinical trials for this vaccine at Accel Research Sites’ DeLand location. He spoke with Orlando’s Fox 35 to share more about what the approval means and the difference between this vaccine and those previously approved.

Watch the segment here.

Back

Ready to be part of healthcare history? Find the right clinical trial for you.

Get In Touch

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.
Accessibility Adjustment

Color Adjustment

Orientation Adjustment

Font Size

 

Line height